Lange termijn prognose na zeer premature geboorte de pops 19 studie
Download
1 / 42

Lange-termijn prognose na zeer premature geboorte: de POPS-19 studie - PowerPoint PPT Presentation


  • 107 Views
  • Uploaded on

Lange-termijn prognose na zeer premature geboorte: de POPS-19 studie. Dr. Martijn J.J. Finken Afdelingen Kindergeneeskunde en Klinische Epidemiologie PAOG nascholing Jeugdgezondheidszorg Maastricht 2009. Uitspraak van een “ex-prematuur”.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Lange-termijn prognose na zeer premature geboorte: de POPS-19 studie' - meena


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Lange termijn prognose na zeer premature geboorte de pops 19 studie

Lange-termijn prognose na zeer premature geboorte: de POPS-19 studie

Dr. Martijn J.J. Finken

Afdelingen Kindergeneeskunde en Klinische Epidemiologie

PAOG nascholing Jeugdgezondheidszorg

Maastricht 2009


Uitspraak van een ex prematuur
Uitspraak van een “ex-prematuur” POPS-19 studie

  • “Het is geen ziekte om te vroeg geboren te zijn, maar het is niet zomaar iets.”


Incidence of very preterm birth
Incidence of very preterm birth POPS-19 studie

CBS-gegevens




POPS populations

  • Project On Preterm and Small-for-gestational-age infants cohort:

    • 94% of all liveborns in the Netherlands in 1983 with:

      • gestational age <32 weeks and/or

      • birth weight <1,500 g


Cohort retrieval
Cohort retrieval populations

Hille, et al. (Pediatrics 2005)


Very preterm birth and development of handicaps
Very preterm birth and development of handicaps populations

Walther, et al. (Early Hum Dev 2000)


Very preterm birth and functional outcomes at 19 y
Very preterm birth and functional outcomes at 19 y populations

Hille, et al. (Pediatrics 2007)


Very preterm birth and functional outcomes at 19 y1
Very preterm birth and functional outcomes at 19 y populations

Hille, et al. (Pediatrics 2007)



Very preterm birth and iq at 19 y
Very preterm birth and IQ at 19 y populations

Weisglas-Kuperus, et al. (Arch Dis Child Fetal Neonatal Ed 2008)


Causes of intrauterine and neonatal growth retardation

Intrauterine growth: populations

Maternal factors:

Maternal height and parity

Intoxications

Medical conditions before or during pregnancy

Placental factors:

Anatomic and functional variants

Fetal factors:

Congenital infections

Syndromes

Hormones: IGF-I, IGF-II, insulin and cortisol

Neonatal growth after preterm birth:

Respiratory distress syndrome

Bronchopulmonary dysplasia

Infections

Inadequate caloric intake

Farmacologic effects: corticosteroids

Causes of intrauterine and neonatal growth retardation


Growth velocity
Growth velocity populations

Wit, et al. (Pediatrics 2006)


Very preterm birth and height development
Very preterm birth and height development populations

Finken, et al. (Pediatrics 2006)


Very preterm birth and perinatal morbidity
Very preterm birth and perinatal morbidity populations

Finken, et al. (Pediatrics 2006)


Very preterm birth catch up growth and adult height
Very preterm birth, catch-up growth and adult height populations

Finken, et al. (Pediatrics 2006)


Preterm birth and insulin resistance at 7 y
Preterm birth and insulin resistance at 7 y populations

Hofman, et al. (NEJM 2004)


Preterm birth and insulin resistance in adulthood
Preterm birth and insulin resistance in adulthood populations

Hovi, et al. (NEJM 2007)


Very preterm birth and body composition at 19 y
Very preterm birth and body composition at 19 y populations

Euser, et al. (Am J Clin Nutr 2005); Finken, et al. (Diabetologia 2006)


Very preterm birth and blood pressure at 19 y
Very preterm birth and blood pressure at 19 y populations

Keijzer-Veen, et al. (Pediatrics 2005)


Birth size childhood growth and later coronary artery disease
Birth size, childhood growth and later coronary artery disease

Eriksson, et al. (BMJ 2001)



Very preterm birth and metabolic profile at 19 y
Very preterm birth and metabolic profile at 19 y y

Euser, et al. (Am J Clin Nutr 2005); Finken, et al. (Diabetologia 2006); Finken, et al. (Pediatr Res 2006)


Very preterm birth and insulin resistance at 19 y
Very preterm birth and insulin resistance at 19 y y

Finken, et al. (Diabetologia 2006)


Catch up growth and later disease causal factor or epiphenomenon

Nutrition y

Catch-up growth

Disease

Catch-up growth and later disease: causal factor or epiphenomenon?



Nutritional intervention in preterm infants1
Nutritional intervention in preterm infants y

Singhal, et al. (Lancet 2003); Singhal, et al. (Lancet 2004)



Nutritional intervention in preterm infants3
Nutritional intervention in preterm infants y

Singhal, et al. (Lancet 2001); Singhal, et al. (Lancet 2003); Singhal, et al. (Lancet 2004)


Maternal behaviour y

Epigenetic modifications

Altered GR expression


Preterm birth and adrenocortical function at 20 y
Preterm birth and adrenocortical function at 20 y y

Szathmari, et al. (Horm Res 2001)


Gr r23k polymorphism very preterm birth and height development
GR R23K polymorphism, very preterm birth and height development

Finken, et al. (JCEM 2007)


Gr r23k polymorphism very preterm birth and metabolic profile at 19 y
GR R23K polymorphism, very preterm birth and metabolic profile at 19 y

Finken, et al. (JCEM 2007)


Long term effects in animals of antenatal glucocorticoid treatment
Long-term effects in animals of antenatal glucocorticoid treatment

  • Raised blood pressure

  • Hyperglycemia

  • Renal morphology and function:

    • Smaller kidneys with less glomeruli

    • Lower GFR


Short term benefits of antenatal glucocorticoid treatment
Short-term benefits of antenatal glucocorticoid treatment treatment

Roberts & Dalziel (Cochrane Datab Syst Rev 2006)


Short term benefits of antenatal glucocorticoid treatment1
Short-term benefits of antenatal glucocorticoid treatment treatment

  • Higher glucose and insulin levels in cord blood

  • Less often inotropic support

Verhaeghe, et al. (JCEM 2005); Moise, et al. (Pediatrics 1995)



Gr n363s polymorphism very preterm birth and waist circumference at 19 y
GR N363S polymorphism, very preterm birth and waist circumference at 19 y

Finken, et al. (in preparation)


Conclusions 1
Conclusions (1) circumference at 19 y

  • Preterm infants have a metabolic profile similar to that of children born SGA

  • Preterm infants with neonatal growth retardation display a growth pattern similar to that of children born SGA

  • At present, there is no trial data available suggesting a beneficial effect of rhGH therapy in short children born very preterm who had experienced neonatal growth retardation


Conclusions 2
Conclusions (2) circumference at 19 y

  • Activation of the HPA axis may contribute to adverse metabolic health after preterm birth

  • The GR R23K variant, associated with decreased sensitivity to glucocorticoids, protects against postnatal growth failure and insulin resistance after very preterm birth

  • The GR N363S variant, associated with increased sensitivity to glucocorticoids, predisposes to adverse body composition after perinatal glucocorticoid treatment in indivduals born very preterm


Recommendations
Recommendations circumference at 19 y

  • Children born very preterm and SGA or experiencing neonatal growth retardation should be flagged

  • Body composition should be monitored throughout childhood

  • Waist circumference is a more valuable tool than BMI for determination of body fatness


ad